<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: <z:hpo ids='HP_0100512'>Vitamin D deficiency</z:hpo> may increase the risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>We therefore investigated whether serum concentrations of 25-hydroxyvitamin D [25(OH)D] would predict the development of <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> (impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi>, <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> or the two combined) and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, either on their own or when combined with serum concentrations of IGF-1 or IGF-binding protein-1 (IGFBP-1), which may interact with 25(OH)D </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: At baseline, participants aged 35-56 years without known type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> were examined using OGTTs, 25(OH)D and IGF <z:chebi fb="7" ids="16670">peptide</z:chebi> measurements, and anthropometric and lifestyle data </plain></SENT>
<SENT sid="3" pm="."><plain>Participants who had <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> or type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> at follow-up 8-10 years later were selected as cases; these were then age- and sex-matched to controls with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance (NGT) at both baseline and follow-up, giving a total of 980 women and 1,398 men </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Men but not women in the highest quartile of 25(OH)D level had a decreased OR for developing type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> after adjustment for confounders (OR 0.52, 95% CI 0.30, 0.90), an effect accounted for by individuals with <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e>, but not with NGT, at baseline </plain></SENT>
<SENT sid="5" pm="."><plain>In both sexes, progression from <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> was reduced by about 25% per 10 nmol/l increase in 25(OH)D </plain></SENT>
<SENT sid="6" pm="."><plain>A high IGFBP-1 value was a better predictor of a reduced risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> than high 25(OH)D for both sexes, whereas high IGF-1 concentrations predicted a decreased risk only in men </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS/INTERPRETATION: High serum 25(OH)D concentrations predict a reduced risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in individuals with <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e>, but not NGT </plain></SENT>
<SENT sid="8" pm="."><plain>There were no significant interactions between 25(OH)D and IGFBP-1 or IGF-1 in terms of risk of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>Our data suggest that <z:chebi fb="27" ids="27300">vitamin D</z:chebi> supplementation should be evaluated for the prevention of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetic</z:e> individuals </plain></SENT>
</text></document>